Regulatory Focus Celegence specializes in regulatory affairs operations and strategy for Life Sciences, presenting a strong opportunity to upsell end-to-end regulatory support, submission management, publishing, and health authority interaction services to mid to large pharma, biotech, and medical device companies expanding global regulatory footprints.

AI Driven The CAPTIS platform and ongoing technology development signals a selling point for clients seeking increased efficiency and accuracy in regulatory submissions; sales conversations can target firms aiming to digitalize literature reviews, document automation, and PMS reporting through scalable tech-enabled solutions.

Global Footprint Celegence operates with a global delivery model and local regulatory insight, which can appeal to multinational Life Sciences customers needing compliant support across regions; potential upsell with expanded geographic coverage, remote staffing, and multilingual regulatory services.

Awarded Credibility Multiple awards including TOPRA Innovation and EcoVadis Bronze, plus CDP climate transparency, provide social proof to prospects prioritizing regulatory excellence, sustainable practices, and innovation; use these credentials in outreach and value storytelling to build trust with potential clients.

Client Expansion Past and ongoing client wins in drug, device, and IVDR spaces (evidenced by NAVignostics collaboration and regulatory tech adoption) indicate opportunities to target high-growth biopharma and diagnostics companies seeking performance and compliance documentation, submissions optimization, and post-market surveillance support.